Evidence map›Paper›PMID 31595038›Full record

ArticleLeukemia2020

In Ph+BCR-ABL1

Michele Baccarani, Ilaria Iacobucci, Sabina Chiaretti, Robin Foà', Poonkuzhali Balasubramanian, Elisabeth Paietta, Letizia Foroni, Sabine Jeromin, Barbara Izzo, Orietta Spinelli and 34 more

Abstract readLetterMulticenter Study
PubMed Publisher
In one paragraph

Article in Leukemia, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Unveiling CrypticInternational journal of molecular sciences · 2025
    Article
  2. Review
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

44 authors.

Michele BaccaraniInstitute of Hematology "L. and A. Seràgnoli", Bologna University, Bologna, Italy. michele.baccarani@unibo.it.
Ilaria IacobucciDepartment of Pathology, St. Jude Children's Cancer Research Hospital, Memphis, TN, USA.
Sabina ChiarettiHeamatology, Department of Precision and Translational Medicine, Sapienza University, Rome, Italy.
Robin Foà'Heamatology, Department of Precision and Translational Medicine, Sapienza University, Rome, Italy.
Poonkuzhali BalasubramanianChristian Medical College, Vellore, India.
Elisabeth PaiettaECOG-ACRIN Leukemia Laboratory, Montefiore Medical Center, New York, NY, USA.
Letizia ForoniHammersmith Hospital, London, UK.
Sabine JerominMLL Munich, Leukemia Laboratory GmbH, Munich, Germany.
Barbara IzzoFederico II University, Naples, Italy.
Orietta SpinelliASST Papa Giovanni XXIII, Bergamo, Italy.ORCID http://orcid.org/0000-0003-0374-1536
Neelam VarmaPGIMER, Chandigarh, India.
Samia MenifInstitut Pasteur, Tunis, Tunisie.
Carolina TerragnaInstitute of Hematology "L. and A. Seràgnoli", Bologna University, Bologna, Italy.
Tulika SethAIIMS, New Delhi, India.
Audrey BidetCHU Bordeaux-Haut Léveque, Bordeaux, France.
Daniel CoriuFundeni Clinical Institute, Bucharest, Romania.
Francesca LunghiSan Raffaele University, Milan, Italy.
Jiri MayerUniversity Hospital and Masaryk University, Brno, Czech Republic.
Barbara ScappiniAOU Careggi, Florence, Italy.
Stephen LangabeerSt. James Hospital, Dublin, Ireland.
Jacqueline MaierUniversitat Leipzig, Leipzig, Germany.
Emma BurtThe Royal London Hospital, London, UK.
Anna CandoniUdine University, Udine, Italy.
Francesco AlbanoBari University, Bari, Italy.
Mario LuppiModena and Reggio Emilia University, Modena, Italy.
Irena ZupanUniversity Clinical Center, Ljubljana, Slovenia.
Thomas LionChildren's Cancer Research Institute, Wien, Austria.
Renata ZadroUniversity Hospital Center, Zagreb, Croatia.
Francesco di RaimondoCatania University, Catania, Italy.
Behzad PoopakIslamic Azada University and Payvand Lab, Tehran, Iran.
Giovanna Rege-CambrinOrbassano Hospital, Turin University, Turin, Italy.
Mario AnnunziataCardarelli Hospital, Naples, Italy.
Ana AyalaUniversidad Nacional de Asuncion, San Lorenzo, Paraguay.
Victor Salinas-ViedmaInstituto de Prevision Social, Asuncion, Paraguay.
Ana Ines PradoHospital Maciel, Montevideo, Uruguay.
Benedict MilnerNHS-Grampian, Aberdeen, UK.
Sara GalimbertiPisa University, Pisa, Italy.ORCID http://orcid.org/0000-0002-4620-0038
Jeroen JanssenDepartment of Hematology, VUMC, Amsterdam, The Netherlands.
Valentina PolliInfermi Hospital, Rimini, Italy.
Lorenzo CombaS.C. Hematology, Cuneo, Italy.
Beatrice BorsellinoAncona University, Ancona, Italy.
Ombretta AnnibaliCampus University, Rome, Italy.
Monica CrugnolaUniversity Hospital, Parma, Italy.
Francesco PassamontiVarese University, Varese, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AdolescentAdultAgedAge FactorsB-LymphocytesChildFemaleFusion Proteins, bcr-ablHumansLeukemia, Myelogenous, Chronic, BCR-ABL PositiveMaleMiddle AgedPrecursor Cell Lymphoblastic Leukemia-LymphomaProto-Oncogene Proteins c-ablYoung AdultABL1 protein, humanBCR-ABL1 fusion protein, humanFusion Proteins, bcr-ablProto-Oncogene Proteins c-abl

Identifiers

PMID31595038

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.